• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Differential regulation of epidermal cell tumor-antigen presentation by IL-1alpha and IL-1beta.

作者信息

Beissert S, Hosoi J, Stratigos A, Brissette J, Grabbe S, Schwarz T, Granstein R D

机构信息

Department of Dermatology, University of Münster, Germany.

出版信息

J Invest Dermatol. 1998 Oct;111(4):609-15. doi: 10.1046/j.1523-1747.1998.00291.x.

DOI:10.1046/j.1523-1747.1998.00291.x
PMID:9764841
Abstract

IL-1 exists in two forms, termed IL-1alpha and IL-1beta, which exert similar effects in a number of biologic models. Recently, there have been reports of some differences in the activities of these two species in some systems. To address this issue with regard to Langerhans cells, Langerhans cell-enriched preparations of epidermal cells were treated with either IL-1alpha or IL-1beta before pulsing with S1509a tumor-associated antigens and subsequent use for immunization of naive mice to S1509a. While epidermal cells treated with 100 U IL-1beta per ml were able to induce protective tumor immunity (as indicated by the rejection of a subsequent tumor challenge with viable S1509a tumor cells), epidermal cells treated with 100 U IL-1alpha per ml failed to confer protective immunity. At 1000 U per ml, IL-1beta also inhibited the ability of epidermal cells to induce tumor immunity. To investigate the effects of the two IL-1 forms on elicitation of tumor immunity, naive mice were immunized against the S1509a tumor by s.c. injection of dead S1509a cells. Epidermal cells enriched for Langerhans cells were treated with either 100 U IL-1alpha or IL-1beta per ml before tumor-associated antigens-pulsing. Epidermal cells were then washed and injected into a hind footpad of tumor immune mice and 24 h footpad swelling was assessed as a measure of delayed-type hypersensitivity. Exposure to IL-1alpha led to suppressed elicitation of delayed-type hypersensitivity, whereas IL-1beta treated epidermal cells elicited a normal (100 U per ml) or enhanced (1000 U per ml) level of delayed-type hypersensitivity. Previous experiments indicated that the suppressive effects of IL-1alpha on induction of immunity may be mediated by TNF alpha. Therefore, the ability of IL-1alpha or IL-1beta to induce epidermal cell production of TNF alpha was assessed. IL-1alpha induced epidermal cells to secrete significantly higher amounts of TNF alpha protein compared with stimulation with IL-1beta. IL-1alpha and IL-1beta appear to differentially regulate epidermal cell antigen presenting capability.

摘要

相似文献

1
Differential regulation of epidermal cell tumor-antigen presentation by IL-1alpha and IL-1beta.
J Invest Dermatol. 1998 Oct;111(4):609-15. doi: 10.1046/j.1523-1747.1998.00291.x.
2
IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells.白细胞介素-10抑制表皮抗原呈递细胞的肿瘤抗原呈递。
J Immunol. 1995 Feb 1;154(3):1280-6.
3
Interleukin 1 alpha but not transforming growth factor beta inhibits tumor antigen presentation by epidermal antigen-presenting cells.白细胞介素1α而非转化生长因子β抑制表皮抗原呈递细胞的肿瘤抗原呈递。
J Invest Dermatol. 1994 Jan;102(1):67-73. doi: 10.1111/1523-1747.ep12371734.
4
Tumor antigen presentation by murine epidermal cells.
J Immunol. 1991 May 15;146(10):3656-61.
5
Tumor antigen presentation by epidermal antigen-presenting cells in the mouse: modulation by granulocyte-macrophage colony-stimulating factor, tumor necrosis factor alpha, and ultraviolet radiation.
J Leukoc Biol. 1992 Aug;52(2):209-17. doi: 10.1002/jlb.52.2.209.
6
Supernatants from UVB radiation-exposed keratinocytes inhibit Langerhans cell presentation of tumor-associated antigens via IL-10 content.紫外线B辐射暴露的角质形成细胞的上清液通过白细胞介素-10含量抑制朗格汉斯细胞对肿瘤相关抗原的呈递。
J Leukoc Biol. 1995 Aug;58(2):234-40. doi: 10.1002/jlb.58.2.234.
7
Tumor antigen presentation by dermal antigen-presenting cells.皮肤抗原呈递细胞的肿瘤抗原呈递
J Invest Dermatol. 2000 Jul;115(1):57-61. doi: 10.1046/j.1523-1747.2000.00014.x.
8
Induction of anti-tumor immunity with epidermal cells pulsed with tumor-derived RNA or intradermal administration of RNA.
J Invest Dermatol. 2000 Apr;114(4):632-6. doi: 10.1046/j.1523-1747.2000.00929.x.
9
Epidermal cell presentation of tumor-associated antigens for induction of tolerance.
J Immunol. 1994 Jul 15;153(2):760-7.
10
Regulation of tumor antigen presentation by urocanic acid.尿刊酸对肿瘤抗原呈递的调节作用。
J Immunol. 1997 Jul 1;159(1):92-6.